ASTS
AST SpaceMobile, Inc.
ASTS has the edge over VRRM overall, supported by stronger modeled upside and stronger fundamentals.
VRRM
Verra Mobility Corporation
VRRM offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
VRRM Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Strong | |
| Under pressure |
VRRM's profitability and cash flow are currently healthy, but its revenue and balance sheet are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
VRRM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 2.6x | $1.96 | — |
| Current | 8.2x | $1.96 | — |
| Cheap | 31x | $7.49 | +282% |
| Fair | 46x | $11.05 | +464% |
| Expensive | 111x | $26.65 | +1260% |
Historical ranges are pointers, not guarantees.
VRRM's PE is in its cheap range at 8.2x. On analysts' estimates for next year's earnings, today's price would be 2.6x.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
VRRM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect VRRM's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
VRRM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.76 | +218% |
| Q3 2026 | $0.24 | -29% |
| Q2 2026 | $0.26 | 0% |
| Q1 2026 | $0.82 | +273% |
| Q4 2025 | $0.85 | +347% |
| Q3 2025 | $0.34 | -43% |
| Q2 2025 | $0.26 | -54% |
| Q1 2025 | $0.22 | -56% |
| Q4 2024 | $0.19 | -47% |
VRRM has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over VRRM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
VRRM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28.3M | -21% |
| Q2 2026 | $25.8M | -22% |
| Q1 2026 | $27.3M | -13% |
| Q4 2025 | $32.7M | +0.7% |
| Q3 2025 | $35.7M | +26% |
| Q2 2025 | $33.2M | +15% |
| Q1 2025 | $31.4M | +19% |
| Q4 2024 | $32.4M | +17% |
VRRM's revenue has slid since its 2022 peak: $28M last quarter, down 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 232% | +22 points |
| Q2 2026 | -127% | -318 points |
| Q1 2026 | 190% | +7.2 points |
| Q4 2025 | 132% | +266 points |
| Q3 2025 | 210% | -16 points |
| Q2 2025 | 191% | -21 points |
| Q1 2025 | 182% | -24 points |
| Q4 2024 | -134% | -218 points |
VRRM has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
VRRM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $89.4M | +83% |
| Q2 2026 | $32.6M | -19% |
| Q1 2026 | $9.6M | -77% |
| Q4 2025 | $5.7M | -73% |
| Q3 2025 | $49M | -42% |
| Q2 2025 | $40.3M | +55% |
| Q1 2025 | $41.7M | +108% |
| Q4 2024 | $21.6M | +12% |
VRRM has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
VRRM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +175K shares |
| 1 year | -6% | -9.7M shares |
| 3 years | -10% | -17.4M shares |
| 5 years | -8% | -13.3M shares |
| Available history | -7.5% | -12.3M shares |
VRRM has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.3M |
| Q1 2026 | $50.2M |
| Q4 2025 | $133.4M |
| Q3 2025 | — |
| Q4 2024 | $148.5M |
| Q3 2024 | — |
| Q4 2023 | — |
VRRM spent $185M buying back its own shares over the past year.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VRRM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.7x | Elevated |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 3.2x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.7x | Elevated |
| Q4 2024 | 3.9x | Elevated |
VRRM's net debt is about 3.7 years of its operating earnings (EBITDA), up from 3.1 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
VRRM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 18.4 | Oversold |
| Stochastic | 2.7 | Oversold |
VRRM's weekly RSI is 18 (oversold) and its Stochastic is 3 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
VRRM PE vs Technology Sector
| Metric | VRRM | Sector median | Relative |
|---|---|---|---|
| PE | 8.2x | 28x | 71% below |
| PE % | 3 | 35 | 32 pts below |
VRRM is trading at 8.2x earnings, a 71% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over VRRM on trend strength, trading above more of its moving averages.
VRRM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.74 | 28% below |
| 20 week MA | $3.67 | 47% below |
| 50 week MA | $10.8 | 82% below |
| 100 week MA | $17.3 | 89% below |
| 200 week MA | $19.7 | 90% below |
VRRM is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over VRRM on returns for 2026, with the stronger performance.
VRRM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.0 | $13.5 | -3.6% |
| 2021 | $13.5 | $15.2 | +12% |
| 2022 | $15.2 | $13.5 | -11% |
| 2023 | $13.5 | $23.0 | +71% |
| 2024 | $23.0 | $24.1 | +4.6% |
| 2025 | $24.1 | $22.5 | -6.6% |
| 2026 YTD | $22.5 | $1.96 | -91% |
VRRM has finished lower in three of the last six years. It's down 91% so far in 2026.